EMA Authorised: Ozawade (pitolisant) — Bioprojet Pharma

View source ↗

Summary

EMA authorised Ozawade (pitolisant) by Bioprojet Pharma. It is indicated for obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Ozawade (pitolisant)

Snippet

Status: Authorised. Therapeutic area: Sleep Apnea, Obstructive. MAH: Bioprojet Pharma. Decision date: 16/10/2025